Marta Albalate

Marta Albalate

Auto-generated profile, based on publicly available information

Marta Albalate

Servicio de Nefrología Hospital Universitario Infanta Leonor Madrid Spain

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Nefrología
Verified
Journal Article
Open access
RPRafael Pérez-García
Rafael Pérez-García
MJMaría Teresa Jaldo
María Teresa Jaldo
MPMarta Puerta
Marta Puerta
MOMayra Ortega
Mayra Ortega
ECElena Corchete
Elena Corchete
RARoberto Alcázar
Roberto Alcázar
Hypomagnesaemia in haemodialysis (HD) is associated with increased mortality risk: its relationship with dialysis fluid (DF). Low concentrations of magnesium (Mg) in blood have been linked to the development of diabetes, hypertension, arrhythmias, vascular calcifications and an increased risk of death in the general population and in haemodialysis patients. The composition of the dialysis fluid in terms of its magnesium concentration is one of the main determinants of magnesium in haemodialysis patients. To study magnesium concentrations in haemodialysis patients, their predictive mortality rate and what factors are associated with hypomagnesaemia and mortality in haemodialysis. Retrospective study of a cohort of prevalent haemodialysis patients followed up for two years. Serum magnesium was measured every six months. The analysis used the initial and average magnesium values for each patient, comparing patients with magnesium below the mean (2.1mg/dl) with those with magnesium above the mean. During the follow-up, three types of dialysis fluid were used: type 1, magnesium 0.5 mmol/l; type 3, magnesium 0.37 mmol/l (both with acetate); and type 2, magnesium 0.5 mmol/l with citrate. We included 137 haemodialysis patients in the study, of which 72 were male and 65 were female, with a mean age of 67 (15) [26-95] years old. Of this group, 57 patients were diabetic, 70 were on online haemodiafiltration (OL-HDF) and 67 were on high-flow haemodialysis (HF-HD). The mean magnesium of the 93 patients with dialysis fluid type 1 was 2.18 (0.37) mg/dl. In the 27 patients with dialysis fluid type 3 it was 2.02 (0.42) mg/dl. And in the 17 with dialysis fluid type 2 it was 1.84 (0.24) mg/dl (p=.01). There was a pronounced direct relationship between Mg and P and albumin. After a mean follow-up of 16.6 (8.9) [3-24] months, 77 remained active, 24 had died and 36 had been transplanted or transferred. Patients with magnesium above than 2.1mg/dl had a longer survival (p=.008). The survival of patients with the three types of dialysis fluid did not differ significantly (Log-Rank, p=.424). Corrected for blood magnesium, patients with dialysis fluid with citrate have better survival (p=.009). The COX regression analysis shows how age, serum albumin, magnesium, dialysis technique and type of dialysis fluid have an independent predictive mortality rate. Low serum magnesium levels have a greater association with an increased risk of mortality compared to high levels. The type of dialysis fluid affects the magnesium concentration and the risk of death.

9 February 2021 in Artificial Organs
Verified
Journal Article
Closed access
PDF file
PMPatricia Martinez-Miguel
Patricia Martinez-Miguel
MAMarta Albalate
Marta Albalate
VDVioleta Durán‐Laforet
Violeta Durán‐Laforet
CPCarolina Peña‐Martínez
Carolina Peña‐Martínez
PSPatricia de Sequera
Patricia de Sequera
DRDiego Rodríguez‐Puyol
Diego Rodríguez‐Puyol


23 January 2021 in Nefrología
Verified
Journal Article
Open access
MCMelissa Cintra
Melissa Cintra
ETEsther Torres
Esther Torres
DSDanilo Salazar
Danilo Salazar
MAMarta Albalate
Marta Albalate
FPFabio Procaccini
Fabio Procaccini
PSPatricia de Sequera
Patricia de Sequera